Treatments for certain diseases, including pancreatic neuroendocrine tumors, renal cell carcinoma, and breast cancer, involve the use of mTOR inhibitors, which may also improve the effectiveness of other cancer treatments [127]. This evidence concerns the gene MTOR and breast cancer.